Episode 5 of the IDDI Podcast Series: Accelerated Approvals shed light on the role of AA in non-oncology trials with discussion on a remarkable AA for an Alzheimer’s disease treatment!
Key Learning Objectives:
- Overview of AA for non-oncology trials: Facts and figures
- Why is there such a predominance of oncology indications nowadays?
- Discussion on a remarkable example in AA for a non-oncology indication
Speakers:
- Everardo Saad, MD: Medical Director, IDDI
- Elisabeth Coart, PhD: Director Statistical Consulting & Research, IDDI
- Moderator: Erik Falvey, Sr. Director Business Development Europe, IDDI
Accelerated Approvals (AA) is an IDDI’s Podcast series brought to you by our leading experts in regulatory statistics and clinical development strategy. This series delves into the mechanisms behind AA, spotlighting the regulatory processes that speed up access to groundbreaking therapies and how IDDI can optimize your clinical development path and reduces time to market.
The podcast series includes six episodes: